Invited Talks, Symposium and Seminar Presentations (2007 - )

Pai M. Serial testing with IFN-g assays: how should we define conversions, reversions and thresholds? Invited presentation at the First Global Symposium on Interferon-g Assays – Rethinking the epidemiology of tuberculosis infection, Vancouver, February 21-22, 2007.

Pai M. IFN-g assays in contact and outbreak investigations: intriguing differences across exposure-gradient studies. Invited presentation at the First Global Symposium on Interferon-g Assays – Rethinking the epidemiology of TB infection, Vancouver, February 21-22, 2007.

Pai M. Tuberculosis infection among household contacts in rural India: comparison of a whole-blood interferon-gamma assay with the tuberculin skin test. Oral presentation at the First Global Symposium on Interferon-g Assays – Rethinking the epidemiology of tuberculosis infection, Vancouver, February 21-22, 2007.

Pai M. Applications of IGRAs in the developing world: what is their potential? Invited presentation at the American Thoracic Society International Conference, San Francisco, May 20, 2007.

Pai M. What is known about interferon-gamma assays and what are the areas of controversy? Invited presentation at the 4th European Regional Congress of the International Union Against Tuberculosis and Lung Disease, Riga, Latvia. June 28, 2007.

Pai M. Research Master Class, Stellenbosch University, Cape Town, South Africa. Title: Confounding in health research: how many ways to skin this cat? August 6, 2007.

Pai M. Screening healthcare workers for TB infection: should T cell assays replace the tuberculin skin test? Invited seminar presentation at the University of Cape Town, South Africa, Aug 13, 2007.

Pai M. New tests for TB infection: what can they contribute to childhood TB diagnosis in high-burden regions? Invited symposium presentation at the 38th World Conference on Lung Health, Cape Town, S Africa, Nov 9-12, 2007.

Pai M, Dheda K. Challenges in the diagnosis of TB among individuals with HIV infection. Invited symposium presentation at the 38th World Conference on Lung Health, Cape Town, S Africa, Nov 9-12, 2007.

Pai M. Role of new T-cell based diagnostic tests to evaluate children and adults exposed to active TB. Invited symposium presentation at the 38th World Conference on Lung Health, Cape Town, S Africa, Nov 9-12, 2007.

Pai M. Introduction of what is known about IGRA tests. Invited presentation at the meeting on Interferon-gamma release assays, KNCV Tuberculosis Foundation, Cape Town, S. Africa, November 13, 2007.

Pai M. IGRA reproducibility, conversions and reversions: longitudinal studies from India. Invited presentation at the meeting on Interferon-gamma release assays, KNCV Tuberculosis Foundation, Cape Town, S. Africa, November 13, 2007.

Pai M. T-cell assay conversions and reversions among contacts of TB patients in rural India. Oral symposium presentation at the American Thoracic Society International Conference, Toronto, May 19, 2008.

Pai M. The diagnosis and misdiagnosis of tuberculosis. Invited presentation at Tropical Diseases: A Clinical and Laboratory Update. Montreal, June 2–4, 2008.

Pai M. New tools and emerging technologies for the diagnosis of active tuberculosis and drug resistance. Invited symposium presentation at the Canadian Respiratory Conference, Montreal, June 20, 2008.

Pai M. Evidence-based TB diagnosis. Invited seminar presentation at the Institute of Infectious Diseases and Molecular Medicine (IIDMM), University of Cape Town, South Africa, July 30, 2008.

Pai M. Introduction to systematic reviews and meta-analysis. Invited guest lecture in the Clinical Research Methods course, Department of Medicine, University of Cape Town, South Africa, July 30, 2008.

Pai M. Evidence-based TB diagnosis. Grand Rounds presentation at the MUHC Medical Grand Rounds, Department of Medicine, McGill University, Montreal, Canada. September 23, 2008.

Pai M. How close are we in differentiating infected from diseased in tuberculosis? Invited symposium presentation at the 39th World Conference on Lung Health, Paris, France, October 16-20, 2008.

Pai M. Evidence for active and passive smoke exposure and increased risk of TB infection, TB disease, and TB mortality. Invited symposium presentation at the 39th World Conference on Lung Health, Paris, France, October 16-20, 2008.

Pai M. Comparison of gamma interferon in human and animal tuberculosis: human. Invited symposium presentation at the 39th World Conference on Lung Health, Paris, France, October 16-20, 2008.

Pai M. Tobacco, TB and mortality in India and China. Invited symposium presentation at the 39th World Conference on Lung Health, Paris, France, October 16-20, 2008.

Pai M. LTBI diagnosis: advances and prospects. Annual Meeting of the Stop TB Partnership New Diagnostics Working Group, 39th World Conference on Lung Health, Paris, France, October 16, 2008.

Pai M. Evidence-based TB Diagnosis: How evidence informs practice and policy. Annual Meeting of the Stop TB Partnership New Diagnostics Working Group, 39th World Conference on Lung Health, Paris, France, October 16, 2008.

Pai M. IGRAs for the diagnosis of LTBI: are they relevant in TB endemic settings? FIND Scientific Forum on Recent Advances in TB Diagnostics, 39th World Conference on Lung Health, Paris, France, October 17, 2008.

Pai M, Scano F. What is the evidence available to support TB infection control interventions? Invited symposium presentation at the 39th World Conference on Lung Health, Paris, France, October 16-20, 2008.

Pai M. Serial Testing for Tuberculosis: Can We Make Sense of T-Cell Assay Conversions and Reversions? BCCDC Public Health Grand Rounds, BC CDC, Vancouver, October 30. 2008.

Pai M. Tuberculosis among healthcare workers in the era of HIV and XDR-TB. Invited seminar presentation at Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia, October 31, 2008.

Pai M.Closing Plenary - New Technologies for TB Diagnosis: What's in the Cards? Ontario Lung Association TB Conference, Toronto, Canada, November 25, 2008.

Pai M. Protecting healthcare workers from TB in the era of HIV and XDR-TB. Invited seminar presentation at the Hinduja Hospital, Mumbai, India, December 18, 2008.

Pai M. Introduction to diagnostic meta-analysis. Workshop presentation at the South Asian Cochrane Centre, Christian Medical College, Vellore, India, January 12, 2009.

Pai M. New diagnostics for tuberculosis: what’s in the pipeline. Invited seminar presentation at St. John’s Research Institute (SJRI), Bangalore, India, January 17, 2009.

Pai M. Diagnosis of tuberculosis: stepping out of Robert Koch’s shadow. Invited symposium presentation at Christian Medical College, Vellore, Winter Symposium 2009, January 22, 2009.

Pai M. New technologies for TB diagnosis: what’s in the pipeline. Invited symposium presentation organized by VM Medical College & Safdarjung Hospital, India International Centre, New Delhi, India, January 20, 2009.

Pai M. Diagnosis of tuberculosis: stepping out of Robert Koch’s shadow. Respiratory Rounds, Ottawa General Hospital, Ottawa, Feb 2, 2009.

Pai M. Diagnosis of latent TB infection: advances and challenges. Pneumo Club, Ottawa, Feb 2, 2009.

Pai M. Effective Use of PubMed and EndNote for Searching and Managing Medical Literature. Workshop presentation at the University of Cape Town, Lung Infection and Immunity Unit, Department of Medicine and the School of Child Health, University of Cape Town, March 9, 2009.

Pai M. New technologies for TB diagnosis: what’s hot and what's not? Invited seminar at the Department of Pediatrics, Chris Hani Baragwanath Hospital, Johannesburg, S Africa, March 10, 2009.

Pai M. Interpreting diagnostic evidence. Invited teaching seminar at the Division of Gynecological Oncology, Department of Obstetrics & Gynecology, Royal Victoria Hospital, McGill University Health Centre, Montreal, April 2, 2009.

Pai M. Evidence-based TB diagnosis: incorporating evidence into new policies. Invited symposium talk at the 5th Union Conference European Region, Dubrovnik, Croatia, May 30, 2009.

Pai M, Joshi R, Gajalakshmi D, Reddy MVR, Kalantri SP. Unstable IGRA conversions and revisions in a high-incidence setting. Oral symposium presentation at the 2nd Global Symposium on IGRAs, Dubrovnik, Croatia, May 30, 2009.

Pai M. Guidelines on IGRAs: concordant or discordant? Invited symposium talk at the 2nd Global Symposium on IGRAs, Dubrovnik, Croatia, June 1, 2009.

Pai M. New diagnostics for TB: Current Status. Invited seminar presentation at the Research Institute of Tuberculosis, Tokyo, Japan, June 30, 2009.

Pai M. Serial Testing for TB Infection: How do We Interpret IGRA Conversions and Reversions? 6th Meeting of Research Unit for TB Infection Diagnostics, Sapporo, Hokkaido, Japan, July 1, 2009.

Pai M. Diagnosis of LTBI in BCG recipients. Invited symposium presentation at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting, San Francisco, USA, Sept 12, 2009.

Pai M, Minion J. Optimism bias, inflated accuracy estimates, and contradicted findings in TB diagnostic research. Invited seminar presentation, Department of Epidemiology & Biostatistics, McGill University, Montreal, October 5, 2009.

Pai M. New tests and biomarkers for LTBI. Invited seminar presentation at the Public Health Laboratory - Toronto, Ontario Agency for Health Protection and Promotion, Toronto, October 8, 2009.

Pai M. Interpreting Interferon Gamma Release Assays - "Show me the data". Invited symposium presentation at the IDSA 47th Annual Meeting, Philadelphia, Oct 31, 2009.

Pai M. Diagnosis of TB infection in HIV-infected persons. Invited symposium presentation at the IDSA 47th Annual Meeting, Philadelphia, Oct 31, 2009.

Pai M. Mapping the landscape and quality of TB diagnostic research. Invited symposium presentation at the Annual Meeting of the Stop TB Partnership's New Diagnostics Working Group, 40th Union World Conference on Lung Health, Cancun, Mexico, Dec 3, 2009.

Pai M. TB Diagnostics: Translating Evidence to Policy and Practice. Invited symposium presentation at the Annual Meeting of the Global Laboratory Initiative, 40th Union World Conference on Lung Health, Cancun, Mexico, Dec 3, 2009.

Pai M. Do IGRAs have a role in developing countries? Invited symposium presentation at the 40th Union World Conference on Lung Health, Cancun, Mexico, Dec 5, 2009.

Pai M. Understanding the epidemiology of smoking and TB. Invited symposium presentation at the 40th Union World Conference on Lung Health, Cancun, Mexico, Dec 5, 2009.

Pai M. Optimism bias, inflated accuracy estimates, and contradicted findings in TB diagnostic research. Beer Seminar, Meakins-Christie Laboratories, Montreal, Feb 1, 2010.

Pai M. Landscape of TB diagnostics in India. ICGEB International Symposium on TB Diagnostics: Innovating to Make an Impact, 16 December 2010, New Delhi, India.

Pai M. TB Diagnosis in 2011: The Good, the Bad and the Ugly. Keystone Symposium on Tuberculosis: Immunology, Cell Biology and Novel Vaccination Strategies, Vancouver, British Columbia, Canada, January 15 – 20, 2011.

Pai M. Squeezing predictive value out of IGRAs. Special Grand Rounds, BC CDC, Vancouver, British Columbia, Canada, January 18, 2011.

Pai M. TB elimination: a realistic goal? World TB Day presentation, McGill AIDS Coalition, McGill University, Montreal, 24 March, 2011.

Pai M. Improving TB diagnosis : difference between knowing the path and walking the path. IFMSA-Québec's Global Health Colloquium. Montreal, 27 March, 2011.

Pai M. Improving TB diagnosis : knowing the path is not the same as walking the path. Scott J. Thaler Lecture Series, AERAS Global TB Vaccine Foundation, Rockville, Maryland, 30 March 2011.

Pai M. Diagnostic research: getting it right and going beyond test accuracy. Invited talk at the Association of Medical Microbiology and Infectious Disease Canada (AMMI) Annual Conference, Montreal, April 7, 2011.

Pai M. Assessing the impact of novel tuberculosis diagnostics. Invited symposium talk at the 3rd North American Congress of Epidemiology, Montreal, June 23, 2011.

Pai M. The medical, public health and economic consequences of bad diagnostics: the case of TB serology. Invited presentation. Diagnostics track. Grand Challenges Meeting, Bill & Melinda Gates Foundation, New Delhi, November 7, 2011.

Pai M. Quality of healthcare in India: the case study of tuberculosis. Invited seminar presentation. Indian Institute of Management, Bangalore, India, 26 December, 2011.